Pharmacy Times
JULY 9, 2024
In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.
STAT
JULY 9, 2024
STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men and 10 women who came to a sprawling medical campus in downtown Buffalo, N.Y., to volunteer for what a news report had billed as “the world’s biggest science project.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 9, 2024
Emily Flaugher, Vice President and General Manager of Health Mart Atlas and Atlas Specialty at McKesson, sat down with Drug Topics to discuss McKesson solutions that help independent pharmacists maximize reimbursement.
STAT
JULY 9, 2024
In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in the pharmaceutical supply chain — wield such “enormous power” that these companies can affect the ability of many Americans to access and afford their medicines. The agency noted that the three largest PBMs processed nearly 80% of the roughly 6.6 billion prescriptions dispensed by U.S. pharmacies in 2023.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 9, 2024
The FTC released its interim report detailing PBM practices, staggering market consolidation statistics, and the disparities between PBMs and their smaller competitors.
STAT
JULY 9, 2024
The overdose crisis is claiming lives across the United States, but it reaches new depths of despair in the criminal justice system. Overdose is the leading cause of death among people returning to their communities after being in jail or prison. Providing addiction treatment in these settings could change that. Roughly 60% of people who are incarcerated have a substance use disorder, in many cases an opioid use disorder.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 9, 2024
Five years ago — before the pandemic — Pfizer’s head of research and development, Mikael Dolsten, told STAT he kept a chess set in his office that he got as a gift from a former CEO of the company. It was a memento delivered to Dolsten after he cautioned his boss that research and development was a long process, like a chess match, not something that would happen quickly.
Drug Topics
JULY 9, 2024
Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.
STAT
JULY 9, 2024
The Human Genome Project was among the most ambitious scientific efforts in modern history, with the aim of deciphering the chemical makeup of the entire human genetic code. The sequence of some 3 billion DNA base pairs that comprise our genome was supposed to be a mosaic, assembled from multiple anonymous people to protect the identity of the volunteer donors.
Fierce Healthcare
JULY 9, 2024
Pharmacy benefit managers (PBMs) have vast power and scale that disadvantages consumers and independent pharmacies, a new report from the Federal Trade Commission argues. | The FTC turned its attention toward pharmacy benefit managers in a new report detailing the consequences of consolidation and vertical integration, warning legal action and regulation could follow.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 9, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. STAT published an investigation this morning on the untold story of the Human Genome Project and ethics concerns surrounding the ambitious project. Check it out here.
pharmaphorum
JULY 9, 2024
A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.Its central message is clear. The six largest PBMs in the US manage nearly 95% of all prescriptions filled in the US, a “concentrated market structure” that has allowed them to “profit at the expense of patients and independent pharmacists,” according to the financial regulator.
Fierce Pharma
JULY 9, 2024
Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team, shaking up its structure, personnel and operations. | Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team. And the division’s newly named commercial chief Christine Roth is among those changes.
Pharmacy Times
JULY 9, 2024
Daily multivitamin users were associated with a 4% higher mortality risk compared to nonusers.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JULY 9, 2024
Learn about the opportunity costs of gene therapies like Beqvez. Discover the obstacles and potential paths forward in the evolving field of gene therapy.
Fierce Pharma
JULY 9, 2024
Ahead of an election in November—and amid a period of legislative uncertainty for the China-targeting BIOSECURE Act—U.S. | Ahead of an election in November—and amid a period of legislative uncertainty for the China-targeting BIOSECURE Act—U.S. House Speaker Mike Johnson has pledged to hold a vote for the controversial bill before the year is out.
Pharmacy Times
JULY 9, 2024
The authors note that the oral, at-home treatment can a better alternative for patients by reducing inconveniences that come with the injectable and nasal administration methods.
European Pharmaceutical Review
JULY 9, 2024
Researchers have developed an ultrasensitive analytical method for quantifying nitrite quantity in process water for pharmaceutical products. The team tested various samples two ion chromatography analytical methods. This included a range of water types eg, purified and potable water, according to the paper. Kumar et al. explained that “accurate determination of nitrite content in process water will support an understanding of the potential for nitrosamine formation from nitrite in process water
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JULY 9, 2024
After languishing in the doldrums for a few quarters, there are signs that the winds of investment are starting to blow again in the US digital health sector.
STAT
JULY 9, 2024
Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated 3.4 billion people, or 40% of the world’s population, are affected by neurological disorders such as Alzheimer’s disease and other dementias, stroke, migraine, depression, anxiety, neonatal encephalopathy, and more. Efforts to expand research that can lead to new and more effective treatments for neurological diseases are sorely needed.
pharmaphorum
JULY 9, 2024
In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.
Drug Topics
JULY 9, 2024
Previously, data from head-to-head trials of tirzepatide and semaglutide were not available.
The Checkup by Singlecare
JULY 9, 2024
Lithium is a generic prescription drug approved by the Food and Drug Administration (FDA) for people ages 7 years and older for the treatment and prevention of manic episodes associated with bipolar I disorder—a mental health condition characterized by episodes of intense mood swings. It’s a relatively low-cost maintenance treatment that has been around for a long time, according to psychiatrist Sid Khurana, MD, the medical director and co-founder of Nevada Mental Health.
Pharmacy Times
JULY 9, 2024
Individuals with tattoos were found to have a greater risk of developing malignant lymphoma, with the risk being highest within 2 years of receiving a tattoo.
STAT
JULY 9, 2024
WASHINGTON — A Massachusetts man has regained his voice after surgeons removed his cancerous larynx and, in a pioneering move, replaced it with a donated one. Transplants of the so-called voice box are extremely rare, and normally aren’t an option for people with active cancer. Marty Kedian is only the third person in the U.S. ever to undergo a total larynx transplant – the others, years ago, because of injuries – and one of a handful reported worldwide.
Pharmacy Times
JULY 9, 2024
Higher vaccination rates were associated with less prevalent asthmatic symptoms, but additional research is needed to confirm these findings.
The Checkup by Singlecare
JULY 9, 2024
If you or someone you know has been diagnosed with Type 2 diabetes , you might have questions about treatment options. Jardiance (empagliflozin) and Trulicit y (dulaglutide) are brand-name medicines that are approved by the Food and Drug Administration (FDA) for blood sugar control in people with Type 2 diabetes. Beyond that, they are very different prescription medications.
Fierce Pharma
JULY 9, 2024
As Gilead Sciences tussles with a web of HIV drug litigation, a high-stakes case tied to patents for prevention medicines is coming back to test the drugmaker. | As Gilead Sciences tussles with a web of HIV med litigation, a case tied to patents for prevention regimens of Truvada and Descovy is not quite settled. Late last week, the U.S. government appealed Gilead's prior win in the fight.
The Checkup by Singlecare
JULY 9, 2024
People with Type 2 diabetes often have difficulty controlling their blood sugar levels, even with dietary changes and regular exercise. Jardiance (empagliflozin) is an oral medication that can help people with Type 2 diabetes maintain lower blood glucose levels, which not only aids in their overall diabetes management but can also lower their risk of cardiovascular disease.
PharmaVoice
JULY 9, 2024
Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.
pharmaphorum
JULY 9, 2024
Roche will reintroduce its Susvimo implant wet AMD, which was withdrawn from sale in 2022 due to manufacturing defects.
Drug Topics
JULY 9, 2024
McKesson’s private brand of OTC health and wellness products are a great way for independent pharmacies to increase profits.
The Checkup by Singlecare
JULY 9, 2024
Latuda (lurasidone) and lithium are two prescription drugs used to treat bipolar disorder. Latuda is an atypical antipsychotic that can be prescribed alone (monotherapy) or with another drug (adjunctive therapy) to improve depressive episodes in people with bipolar I disorder. It’s also approved by the Food and Drug Administration (FDA) to treat schizophrenia.
Expert insights. Personalized for you.
149 
Let's personalize your content